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Abstract
Objective: Adenosine participates in maintaining the excitatory/inhibitory balance in neuronal 
circuits. Studies indicate that adenosine levels in the cortex and hippocampus increase and exert 
sleep pressure in sleep-deprived and control animals, whereas in epilepsy reduced adenosine tone 
promotes hyperexcitability. To date, the role of adenosine in pathological conditions that result in 
both seizures and sleep disorders is unknown. Here, we determined adenosine tone in sleep and 
seizure regulating brain regions of Kv1.1 knockout (KO) mice, a model of temporal epilepsy with 
comorbid sleep disorders.
Methods: 1) Reverse phase-high performance liquid chromatography (RP-HPLC) was performed 
on brain tissue to determine levels of adenosine and adenine nucleotides. 2) Multi-electrode array 
extracellular electrophysiology was used to determine adenosine tone in the hippocampal CA1 
region and the lateral hypothalamus (LH).
Results: RP-HPLC indicated a non-significant decrease in adenosine (~50%, p = 0.23) in whole 
brain homogenates of KO mice. Regional examination of relative levels of adenine nucleotides 
indicated decreased ATP and increased AMP in the cortex and hippocampus and increased 
adenosine in cortical tissue. Using electrophysiological and pharmacological techniques, estimated 
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adenosine levels were ~35% lower in the KO hippocampal CA1 region, and 1–2 fold higher in the 
KO LH. Moreover, the increased adenosine in KO LH contributed to lower spontaneous firing 
rates of putative wake-promoting orexin/hypocretin neurons.
Interpretation: This is the first study to demonstrate a direct correlation of regionally distinct 
dichotomous adenosine levels in a single model with both epilepsy and comorbid sleep disorders. 
The weaker inhibitory tone in the dorsal hippocampus is consistent with lower seizure threshold, 
whereas increased adenosine in the LH is consistent with chronic partial sleep deprivation. This 
work furthers our understanding of how adenosine may contribute to pathological conditions that 
underlie sleep disorders within the epileptic brain.
Keywords
Mitochondria; Kv1.1 knockout; Cerebral cortex; Hippocampus; Lateral hypothalamus
1. Introduction
Persistent disturbances in sleep architecture and quality are commonly associated with many 
neurological and psychiatric disorders, including epilepsy (St. Louis, 2011; Krause et al., 
2017). Adenosine is a neuromodulator that elicits antiseizure and somnogenic actions. 
Adenosine tone has an inhibitory effect on excitatory synapses via the adenosine 1 receptor 
(A1R) throughout the brain (Dunwiddie, 1980). During temporal lobe seizures, adenosine 
levels rise which suppresses further seizure activity (Winn et al., 1980). However, in cases of 
chronic epilepsy this inhibitory mechanism is weakened or lacking as seen in animal models 
and humans with lower adenosine tone (Rebola et al., 2003; Masino et al., 2011; Boison, 
2016; Porkka-Heiskanen et al., 1997). As a somnogen, adenosine levels have been reported 
to rise in specific cortical, temporal, and subcortical brain regions when wake periods exceed 
physiological durations (Porkka-Heiskanen et al., 2000; Basheer et al., 2004; Weber and 
Dan, 2016). Rising adenosine levels are thought to promote sleep by inhibiting neurons 
involved in wakefulness and cognition; thus, decreased levels may be responsible for sleep 
disruption (Boison and Aronica, 2015). For individuals with both epilepsy and sleep 
disruption, a logical, yet untested, hypothesis is that a uniformly reduced adenosine tone 
underlies both conditions (Boison, 2016).
Here we determined the adenosine tone in Kv1.1 knockout (KO) mice, a model of epilepsy 
with comorbid sleep disorders. KO mice lack the α-subunit of the Kv1.1 voltage-gated 
delayed rectifier potassium channel, have a severe epilepsy phenotype with multiple types of 
seizures, including frequent generalized tonic-clonic seizures, and present pathology similar 
to temporal lobe epilepsy (Smart et al., 1998; Wenzel et al., 2007; Simeone et al., 2016). We 
have recently reported that KO mice also have sleep-disorder symptoms consistent with 
involvement of the orexin/hypocretin system, including disrupted sleep architecture and 
insufficient amounts of non-rapid eye movement (NREM) sleep and rapid eye movement 
(REM) sleep (Roundtree et al., 2016).
Orexin/hypocretin neurons are a subset of wake-promoting neurons located in the lateral 
hypothalamus (LH). Severe seizures propagate to the LH in KO mice, and the LH displays 
signs of chronic pathology (including increased blood-brain permeability, astrogliosis and 
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impaired mitochondrial function) and increased orexin/hypocretin protein levels (Roundtree 
et al., 2016). Orexin/hypocretin neurons express A1R and their inhibition is known to 
promote sleep (Chemelli et al., 1999; Liu and Gao, 2007). Thus, we hypothesized that 
adenosine concentrations would be lower in KO hippocampus and LH providing a common 
etiology for ictogenesis in the hippocampus and for the sleep disorders seen in the LH of KO 
mice. Contrary to our hypothesis, our data indicate regionally divergent adenosine tones in 
KO brain indicating a hitherto unrecognized complexity in the regulation of adenine 
nucleotides during complex and chronic neurological disorders.
2. Methods
2.1. Animals
C3HeB/FeJ Kv1.1 knockout (KO) and wild-type (WT) littermates were bred, reared, 
genotyped, and housed as previously described (Roundtree et al., 2016). Mice were 
entrained to a strict 12 h light/dark cycle with access to food and water ad libitum. Lights on 
occurred at zeitgeber time (ZT) 00:00 h. For all electrophysiology experiments, mice were 
sacrificed between 03:00–04:00 ZT to control for diurnal changes in adenosine levels in the 
brain. Adult male and female mice (5–9 weeks old) were used for these experiments. All 
experiments conformed to NIH guidelines in accordance with the United States Public 
Health Service’s Policy on Humane Care and Use of Laboratory Animals and were approved 
by Creighton University’s Institutional Animal Care and Use Committee.
2.2. Reversed-phase high pressure liquid chromatography (RP-HPLC) tissue extraction
For RP-HPLC experiments, mice were euthanized using a Muromachi Microwave Fixation 
System (Model MMW-05, Muromachi Kikai Co., LTD, Tokyo, Japan) in order to quickly (< 
1 s) raise the brain temperature above 85 °C and inactivate enzymatic activity. This is 
necessary in order to prevent post-mortem ATP/ADP/AMP metabolism by nucleotidase 
activity and accumulation of adenosine as a technical artifact. Mice were initially 
anesthetized using isoflurane and placed in a restrainer with a water jacket and euthanized 
(3.5 kW and 0.89 s); (Delaney and Geiger, 1996). The whole brain was removed and 
examined for proper fixation then immediately placed in 0.1 M sulfuric acid and 
homogenized on ice. Tris (0.1 M) base was added to homogenized tissue in sulfuric acid 
followed by 1 M NaOH to neutralize the homogenate. The neutralized homogenate was 
centrifuged at 15 rcf for 15 min at 4 °C. Supernatant was collected for RP-HPLC (Akula et 
al., 2008). Adenosine concentrations from whole brains were normalized to protein 
concentration as determined using the Bradford method performed on a sample of each 
homogenate.
2.3. HPLC analysis of whole brain tissue
Conversion of adenosine to the N6-etheno derivative was accomplished by a previously 
published method (Haink et al., 2003). Briefly, standards or the extraction solution (8 mice 
total 50 μL) was added to a freshly prepared mixture of chloroacetaldehyde (~50% in water 
from Aldrich) and sodium acetate buffer (1 M, pH 4.5) (11.2/138.8, v/v, 150 μL). After 
heating at 60 °C for 1 h, the mixture was cooled in ice water to stop the reaction, filtered 
through a 0.45 μm membrane and used without dilution for RP-HPLC analysis. RP-HPLC 
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was performed on a Waters 626 instrument equipped with a 600S controller, a 474 scanning 
fluorescence detector and a 717plus autosampler. Analysis of etheno-derivatized standards 
and extracts was performed by a previously published method modified to separate N6-
ethenoadenosine from interfering peaks derived from mouse brain (Bhatt et al., 2012). 
Separation was achieved on a Waters XTerra MS C18 column (3 × 50 mm, 5μm), equipped 
with a C18 guard cartridge (Phenomenex, Torrance, CA), eluted with mixtures of buffer A 
(tetrabutylammonium-hydrogensulfate (5.7 mM) and KH2PO4 (30.5 mM) adjusted to pH 5.8 
with 2 M KOH) and buffer B (acetonitrile/buffer A, 2/1, v/v) at 1.5 mL/min. Samples of the 
derivatizing mixture (50 μL) were loaded on to the column, which had been previously 
equilibrated with buffer A. The column was eluted by increasing the percentage of buffer B 
in the eluent to 40% over 1 min, holding buffer B at 40% for 1.4 min before reducing the 
percentage of buffer B back to 0% over 0.1 min. The column was then washed with buffer A 
for 2.5 min before the next sample was loaded. The eluent was continuously monitored for 
fluorescence employing an excitation wavelength of 280 nm and an emission wavelength of 
410 nm (Bhatt et al., 2012). N6-ethenoadenosine eluted from the column after 1.7 min. 
Quantification of adenosine amounts was determined using external standards (25–1000 nM, 
r2 = 0.9996).
2.4. HPLC analysis of adenine nucleotides in specific brain regions
Determination of the concentration of adenine nucleotides followed Levitt et al. (1984). 
Microwaved fixed brain tissues were homogenized (9 mice total,) in 75% MeOH/0.15 M 
NaCl to 0.5 mg/mL W/V. The homogenate was combined with 0.15 M NaCl and CHCl3/
MeOH (2:1 v/v) containing 0.01% BHT. Samples were vortexed for 2 min and phases were 
allowed to separate for 30 min on ice. After separation, samples were centrifuged for 5 min 
at 7.8 kg. The lower phase was removed for nonpolar metabolite analysis while the upper, 
aqueous phase was saved for polar metabolite analysis. To compare adenine nucleotide 
concentrations, the aqueous portion was converted to its etheno adduct. The aqueous extract 
was dried under nitrogen then resuspended in a 10:1 (v/v) mixture of Krebs buffer (in mM): 
113 NaCl, 4.8 KCl, 2.5 CaCl2, 1.2 KH2PO4, 1.2 MgSO4, 25 NaHCO3 and 5.5 glucose) and 
chloroacetaldehyde. Samples were heated to 80 °C for one hour then cooled to room 
temperature for HPLC analysis. HPLC consisted of a Shimadzu LC-20AB binary pump 
connected to a Shimadzu RF-20Axs fluorescent detector. Five μL of the derivatized samples 
were injected onto an Agilent Eclipse AAA 4.6 × 150 mm column at a flow rate of 0.8 mL/
min. Mobile phase A consisted of 0.1% formic acid and mobile phase B consisted of 0.1% 
formic acid in acetonitrile, and the following gradient was used to separate the adenosine 
molecules: initial conditions of 0% B was held for 5 min, followed by increases to 4.7% B 
over 2 min, 11.7% B over 8 min, 35% B over 5 min, 95% B over 5 min then held for 5 min 
at 95% B. The column was then returned to initial conditions and held for 5 min. Etheno 
detection was achieved using an excitation wavelength of 300 nm and an emission 
wavelength of 420 nm. The adenylate energy charge (AEC) was calculated with the 
following equation:
Energy cℎarge = [ATP ] + 1/2[ADP ][ATP ] + [ADP ] + [AMP ]
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2.5. Acute slice preparation and multi-electrode array recordings
WT and KO mice were anesthetized with isoflurane and decapitated. The brains were 
quickly placed into an ice-cold no Mg2+-sucrose aCSF continuously bubbled with carbogen 
(95% O2/5% CO2) containing (in mM): 206 sucrose, 2.8 KCl, 8 MgSO4, 26 NaHCO3, 1.25 
NaH2PO4, and 10 glucose, (pH 7.4, Osm 294). Coronal slices (400 μm) were prepared on a 
Leica VT1200 and transferred to a holding chamber at room temperature (RT) for at least 1 
h before recordings. Recordings were taken in an aCSF containing (in mM): 124 NaCl, 2.8 
KCl, 2.4 CaCl2, 2.5 MgSO4, 26 NaHCO3, 1.25 NaH2PO4, and 25 glucose (pH 7.4, 295 
mOsm). Slices were appropriately positioned over the electrode grid of a MED64 probe 
(Alpha Med Systems, Osaka, Japan; array size: 1 × 1 mm; each electrode: 50 × 50 μm; 
interpolar distance: 150 μm; 8 × 8 electrode array) and perfused at a rate of 1 mL/min with 
in-line pre-warmed (~33 °C) aCSF bubbled continuously with carbogen.
2.6. Electrophysiology recording protocols
An electrode in the Schaffer collateral pathway was chosen for stimulation and responses 
recorded by electrodes in the stratum radiatum of the CA1 (CA1sr) in hippocampal slices 
(13 mice). For slices containing LH, the medial forebrain bundle fiber tract was stimulated 
and responses recorded by electrodes in the perifornical area of the LH. An I/O curve was 
generated for synaptic responses with sequential stimulations (−10 to −180 μA) every 20 s. 
A stimulation intensity that elicited 40–60% of the maximum output was chosen for 
experiments and stimulations occurred every 60 s. Field excitatory postsynaptic potentials 
(fEPSPs) slopes (10–90%) were analyzed. A baseline measurement consisted of at least 10 
min of stable recordings before 10 μM of the A1R antagonist, 2-[4-(2,3,6,7-Tetrahydro-2,6-
dioxo-1,3-dipropyl1H-purin-8-yl)phenoxy]-acetic acid (XCC, Tocris) was applied.
For recordings of extracellular action potentials in the LH, spontaneous events from all 64 
channels were recorded in continuous, gapfree mode with Mobius software (WitWerx Inc., 
Tustin, CA) and acquired at a 20 kHz sampling rate with a bandwidth of 10 Hz–10 kHz (7 
mice total). Spontaneous activity was recorded from the LH over a period of 5 min. XCC 
was perfused into the chamber for a period of 10 min before recordings resumed.
2.7. Principal Component Analysis (PCA)
Traces from spontaneous activity within the LH were imported into Spike2(v7) (Cambridge, 
England) for filtering and PCA to distinguish between principal cells and interneurons. 
Single unit analysis was carried out according to the specifications in Simeone et al. (2013). 
Individual traces were filtered with FIR 300–3000 Hz band pass filter. Four times the root 
mean square (RMS) of the noise of the trace was calculated and served as the threshold for 
spike detection. After the separation and classification of the units (action potentials) into 
clusters representing individual neurons, PCA was performed to check precision and refine 
the initial clustering analysis. Principal cells with a firing frequency below 0.01 Hz were 
excluded from analysis.
2.8. Estimating local adenosine concentrations
Adenosine concentrations were determined in the hippocampus and the LH following the 
method of Dunwiddie and Diao (1994). Evoked and spontaneous activity were recorded 
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before and after a saturating concentration (10 μM) of the A1 receptor antagonist XCC. The 
fractional increase (f.i.) of activity was then used to estimate the endogenous adenosine 
concentration, with the following equation:
[Adenosine]endogenous = (f . i . )1/H × EC50
where H is the Hill slope (1.52, estimated by Dunwiddie and Diao, 1994), and EC50 is the 
adenosine concentration that produces a half-maximal response (610 nM, estimated by 
Dunwiddie and Diao, 1994).
2.9. Statistics
All experiments were analyzed with the Student’s t-test, unless otherwise noted. A p-value < 
0.05 was considered statistically significant. All statistical analyses were done using Prism6 
software (Graphpad Software, Inc., La Jolla, CA).
3. Results
3.1. Relative adenosine and adenine nucleotide ratios are altered in the KO brain
Initial RP-HPLC experiments indicate similar adenosine levels in whole brain samples from 
KO mice (by 46.3 ± 14%) and WT mice (Fig. 1; p = 0.227). Adenosine exists in a futile 
regulatory cycle with energy-transfer molecules adenosine triphosphate (ATP), −diphosphate 
(ADP), and -monophosphate (AMP). To detect regional differences, we determined the 
relative amounts of adenosine and adenine nucleotides in the hippocampus and cortex. Both 
WT hippocampus and cortex contained the expected graded ratios of adenine nucleotides 
with ATP representing the largest proportion (45% ATP, 34% ADP, 20% AMP, and 1% 
adenosine; Fig. 2A,B) with low coefficient of variations (CV) (Fig. 2C–F). In contrast, KO 
levels of ATP, ADP, and AMP were similar with large CVs. KO hippocampal proportions 
were 36% ATP, 30% ADP, and 33% AMP with no change in adenosine (1%). Similarly, KO 
cortical ratios were 30% ATP, 25% ADP, and 35% AMP, however, adenosine was increased 
to 10%. The shifting proportions adenine nucleotides resulted in a ~20% decrease in the 
overall adenylate energy charge in KO brain (Fig. 3). Collectively, these data suggest a 
dysregulation of energy-storage capacity in KO brain.
3.2. Basal adenosine levels are reduced in KO hippocampus
Electrophysiology and pharmacology was used to determine adenosine tone in local regions 
that regulate ictogenesis and sleep. First, we tested the hypothesis that adenosine inhibitory 
tone was reduced in the ictogenic hippocampus. We placed the CA1 region of a hippocampal 
slice on a 64-electrode array, stimulated the Schaffer collaterals and recorded extracellular 
dendritic field potentials in the CA1sr (Fig. 4A–C). KO fEPSP 10–90% slopes were 19 ± 
2% smaller than WT slopes (p < 0.167). Application of a saturating concentration of the 
A1R antagonist, XCC (10 μM) increased fEPSP slopes significantly in both WT and KO 
slices. Antagonizing A1Rs increased the field potential slope by 35.5 ± 5% in WT CA1sr 
and 19.3 ± 5% in KO CA1sr (p < 0.0001, Fig. 4D). From these fractional increases, an 
estimate of endogenous adenosine was calculated (see Methods; Dunwiddie and Diao, 1994; 
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Sandau et al., 2016). Adenosine levels in CA1sr were 35.4 ± 4% lower in KO when 
compared to WT CA1sr (p < 0.05, Fig. 4E) suggesting a weaker inhibitory tone in the KO 
hippocampus.
3.3. Basal adenosine levels are increased in the KO LH
Increased orexinergic tone was implicated in the sleep disorders of KO mice since an orexin 
receptor antagonist improved sleep (Roundtree et al., 2016). We tested the hypothesis that 
adenosine inhibitory tone was reduced in the orexin-rich LH. LH slices were placed on a 64-
electrode array, the medial forebrain bundle fiber tract, which runs through the LH, was 
stimulated and extracellular field potentials in the perifornical area of the LH were recorded 
(Fig. 5A, B). Units were identified as belonging to single neurons using PCA, and principal 
cells or interneurons were distinguished based on their spike width and asymmetry (Fig. 5B, 
C). KO field potential 10–90% slopes were 30.7 ± 10.8% smaller than WT slopes. Following 
A1R inhibition with XCC (10 μM), WT field potential slopes increased by 7.9 ± 1.2% 
compared to an 18.1 ± 2.9% increase of KO slopes; both values were significantly different 
from baseline (WT p < 0.0001; KO p < 0.0001) and from each other (WT v. KO p < 0.001; 
Fig. 5D). The estimated adenosine tone in the LH of KO mice was 84.6 ± 1.9% greater than 
WT (Fig. 5E, p < 0.001). In addition, XCC restored KO field potentials to near WT values 
(Fig. 5D, p = 0.15) suggesting that the smaller KO postsynaptic responses are partially due 
to increased adenosine-mediated inhibition.
Interneurons and orexin neurons in the LH are spontaneously active (Schöne et al., 2011; 
Karnani et al., 2013) (Fig. 5B), therefore, effects of XCC on action potential firing rates 
provide another method to determine endogenous adenosine concentrations. Using the 
multi-electrode array, we performed extracellular recordings of spontaneous action 
potentials (or units) in electrodes in the perifornical-LH. Interneurons accounted for 93.0% 
of the WT LH activity and 87.4% of KO activity. There was no statistical difference between 
the spontaneous firing rates of interneurons between the genotypes (p = 0.42) and XCC did 
not alter firing rates (WT: p = 0.13; KO: p = 0.71). In contrast, KO principal cells, or 
putative orexin neurons, fired at 20.3 ± 7% of the rate of their WT littermates (p = 0.03; Fig. 
5F). The average fractional increase of the firing frequency with XCC was 43.9 ± 12% in 
WT and 97.9 ± 38% in KO LH following bath application with the A1R antagonist (Fig. 5F 
WT, p = 0.001; KO, p = 0.002). Similar to the field potential findings, this resulted in 
adenosine concentrations that were higher (192.8 ± 72%) in KO LH compared to WT levels 
(Fig. 5G; p < 0.05). Collectively, these data indicate that adenosine is 1–2 fold higher in KO 
LH contrary to our original hypothesis.
4. Discussion
The current study is the first to measure adenosine levels in the sleep-promoting LH and is 
the first to determine adenosine levels in seizure-genic and sleep-related brain regions in a 
single model of epilepsy with comorbid sleep disorders. First, we present evidence that 
overall energy charge storage in adenine nucleotides is decreased throughout the brain, 
supporting our previous findings of widespread mitochondrial dysfunction in regions 
including the cortex, hippocampus, and hypothalamus (Roundtree et al., 2016; Simeone et 
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al., 2014; Kim et al., 2015). Second, we demonstrate and confirm that hippocampal 
adenosine decreases in epilepsy (Rebola et al., 2003; Boison, 2016; Li et al., 2007). Third, 
and most importantly, our data indicate adenosine increases in the sleep-promoting epileptic 
cortex and lateral hypothalamus.
Physiological concentrations of adenosine serve as neuromodulators in the hippocampus that 
contribute to appropriate excitatory/inhibitory balance (Cunha, 2016). Intense neuronal 
activity during seizures causes the release of ATP from glia and synaptic vesicles which is 
subsequently broken down to adenosine by ectonucleotidases. The increase of extracellular 
adenosine aids in limiting excessive excitability and can contribute to the termination of a 
seizure by hyperpolarizing neurons via A1R activation and subsequent ion channels (Masino 
et al., 2011). However, in the epileptic hippocampus, numerous studies (in murine, rat, and 
human) demonstrate upregulation of adenosine kinase (ADK), which results in an adenosine 
deficiency and subsequent cellular and network hyperexcitability (Rebola et al., 2003; 
Masino et al., 2011; Sandau et al., 2016; Gouder et al., 2004; Aronica et al., 2011; de Groot 
et al., 2012).
Adenosine’s role in sleep is more nuanced. In brain regions involved in promoting 
wakefulness, such as the basal forebrain, cortex, and even the hippocampus, adenosine 
increases with the amount of time spent awake exerting inhibitory pressure to drive sleep 
(Basheer et al., 2004; Weber and Dan, 2016). This natural phenomenon is exacerbated 
during prolonged or chronic sleep deprivation or restriction, and decreases in adenosine tone 
may contribute to sleep disorders (Coleman et al., 2006; Hines et al., 2013).
It has been proposed that brain-wide decreases in adenosine may promote hyperexcitability 
in epilepsy; and contribute to sleep and cognitive comorbidities in epilepsy, Alzheimer’s 
disease, Parkinson’s disease, and Amyotrophic Lateral Sclerosis (Boison, 2016). Thus far, 
the evidence for this possibility relies on findings of increased expression of ADK in brain 
tissue from human epilepsy, Alzheimer’s, Parkinson’s, and ALS patients. ADK is 
upregulated in GFAP-expressing reactive astrocytes and phosphorylates adenosine to AMP. 
Intracellular and extracellular adenosine levels are in equilibrium via passive equilibrative 
nucleotide transporters expressed by glia and neurons; thus, increased ADK reduces 
adenosine. The best evidence that decreases in adenosine can result in multiple phenotypic 
comorbidities comes from studies of global upregulation of ADK in transgenic (Adk-tg) 
mice. Adk-tg mice have a 50% reduction of tissue levels of adenosine, spontaneous recurrent 
seizures, severe learning deficits, altered locomotor control, and sleep deficiencies (Li et al., 
2007; Yee et al., 2007; Shen et al., 2011; Shen et al., 2012). The above mentioned expression 
studies on human resected or postmortem tissue assess only regions subjected to insult or 
trauma, and not necessarily sleep-regulating regions (which may or may not be damaged). 
Therefore, it is not known whether adenosine tone is altered in regions relevant to specific 
comorbidities such as sleep.
In an attempt to provide further evidence for adenosine’s role in both epilepsy and sleep 
comorbidities, the current study used a mouse model of epilepsy with sleep disorders that is 
not directly related to the adenosinergic system. We found similar levels of ATP, ADP, and 
AMP in KO mice. Future studies will need to determine whether this reflects changes in 
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adenosine metabolizing enzymes. However, it has been reported that global mitochondrial 
dysfunction in ATP-producing complex I of the electron transport chain occurs in the KO 
cortex, hippocampus, and hypothalamus (Roundtree et al., 2016; Simeone et al., 2014; Kim 
et al., 2015). Within these regions, complex I is inhibited by excessive reactive oxygen 
species (ROS) correlating with the wide spread damage in the hippocampus and elsewhere 
(Wenzel et al., 2007; Roundtree et al., 2016; Simeone et al., 2014; Kim et al., 2015). 
However, sleep deprivation also induces mitochondrial dysfunction and KO mice are 
significantly sleep deficient (Roundtree et al., 2016; Ramanathan et al., 2002; Andreazza et 
al., 2010). Regardless of the precipitating cause of mitochondrial dysfunction, these studies 
support our current HPLC results which indicate a general decrease of ATP and an 
accumulation of adenosine in lower energy molecules ADP, AMP, and adenosine. 
Alternatively, the decreased ATP and increased AMP/ATP ratios could reflect increased 
usage of ATP, which has been reported to occur during seizures and extended wakefulness 
(Hardie and Frenguelli, 2007; Dworak et al., 2010).
Although whole brain HPLC suggested overall decreases in KO adenosine, regional HPLC 
and electrophysiology experiments demonstrated increased adenosine in sleep-related cortex 
and LH and a reduction in seizure-related hippocampus. One possible explanation may be 
regional differences in damage. For example, Wenzel et al. (2007) found wide spread cell 
death and GFAP-expressing reactive astrocytes in the same KO model used herein, 
specifically in the hippocampus, neocortex, piriform cortex, thalamus, and amygdala 
consistent with environments resulting in increased ADK. In the LH of KO mice we have 
found evidence of minor damage, limited to BBB permeability and increased GFAP-
expressing reactive astrocytes, but no cell death (Boison, 2016; Roundtree et al., 2016). 
However, few LH astrocytes actually express GFAP, therefore, even though we observed a 
doubling, these increases may be relatively inconsequential for ADK expression. 
Collectively, these results suggest that mitochondrial dysfunction contributes to a decrease in 
ATP production and that the regional expression of ADK may determine in which areas ATP 
metabolite adenine nucleotides accumulate. Further studies are warranted to further clarify 
the relationships between mitochondrial ADP usage-ATP production, and changes in 
adenosine metabolizing enzymes.
In the hippocampus, the reduced levels of adenosine may have predicted disinhibition and 
thus larger baseline fEPSPs in the CA1 of KO mice. In contrast, fEPSP were smaller in KO 
when compared with WT mice. This may be due to the loss of Kv1.1 itself, which may cause 
depolarization of the resting membrane and shunting of excitatory inputs resulting in 
reduced transmitter release. However, this is unlikely as loss of Kv1.1 is associated with 
increased synaptic strength (Simeone et al., 2013). Alternatively, the Schaffer-collateral 
axons that were stimulated to produce the fEPSPs rely heavily on ATP for synaptic 
neurotransmitter release. Reduced mitochondrial production of ATP may contribute to 
decreased synaptic strength in KO hippocampus (Liotta et al., 2012).
In sleep regulating regions, we found KO adenosine levels were increased, supporting 
previous associations of sleep deficiency and elevated adenosine. In the LH, A1Rs are 
expressed on a subset of principal cells, the wake-promoting orexin neurons that project to 
arousal nuclei of the reticular activating system, thalamus, basal forebrain, and other cortical 
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and limbic regions to trigger wakefulness (Thakkar et al., 2002). Consistent with increased 
adenosine and inhibition of orexin neurons during sleep deprivation, baseline LH field 
potentials are smaller and baseline firing frequencies of putative orexin neurons are slower in 
KO LH (Grivel et al., 2005; Matsuki et al., 2015). Further, A1R antagonism restores these to 
near WT levels.
While this scenario suggests that sleep would be improved, chronic sleep deficiency persists 
in KO mice (Iyer et al., 2018). This may be due to the increased number of orexin neurons in 
KO LH (Roundtree et al., 2016). Even though the activity of orexin neurons is decreased, the 
net orexinergic output may be increased. This notion is supported by our findings that 
administration of an orexin receptor antagonist was highly effective at improving sleep and 
reducing seizures in KO mice (Roundtree et al., 2016). Alternatively, adenosine tone may be 
reduced in one or more of the other sleep-promoting regions. Another possibility is that the 
seizures themselves are promoting sleep deficiency. We have reported that severe seizures 
are able to propagate to the LH of KO mice, thus potentially directly activating wake-
promoting circuitry (Roundtree et al., 2016). Further, the subsequent pathology including 
impaired mitochondrial ATP production may contribute to sleep deficiency. The brain-wide 
net decrease in adenylate energy charge storage and availability could cause the breakdown 
of homeostatic stability and result in cellular hyperexcitability, degradation of synaptic 
precision, and the inability to maintain energy-demanding network oscillations such as REM 
(Brown et al., 2012; Porkka-Heiskanen, 2013). Indeed, KO mice have significantly less 
REM than WT mice and REM deficiency strongly correlates with seizure severity 
(Roundtree et al., 2016). Indeed, KO mice have significantly less REM than WT mice and 
REM deficiency strongly correlated with seizure severity (Roundtree et al., 2016). The 
interdependent relationship between seizures and sleep deficiency is complex as each 
negatively exacerbates the other. We have reported that improving sleep with a melatonin 
receptor agonist or an orexin receptor antagonist reduces seizures (Roundtree et al., 2016; 
Fenoglio-Simeone et al., 2009a), and that reducing seizures with the ketogenic diet improves 
sleep (Iyer et al., 2018; Fenoglio-Simeone et al., 2009b). Future studies are required to 
untangle sleep deficiency from seizures.
In summary, we have demonstrated that regulation of adenosine tone is regionally diverse in 
epilepsy with comorbid sleep disorders, thus disproving the assumption that global, uniform 
changes in adenosine may underlie both syndromes. Whether uniform or dichotomous 
alterations in adenosine tone occur in other relevant models of epilepsy, Alzheimer’s 
disease, Parkinson’s disease, or ALS with sleep or cognitive comorbidities remain unknown, 
and will need to be determined in future studies. This work furthers our understanding of 
how adenosine may contribute to pathological conditions that underlie sleep disorders within 
the epileptic brain and suggests that treatments designed to modify the adenosinergic system 
may need to be targeted to specific regions.
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Whole brain adenosine levels in KO and WT mice.
Focal microwave irradiation ensured fidelity of endogenous adenosine levels by limiting 
enzymatic activity within the tissue. Adenosine concentrations of whole brain were 
normalized to the protein concentration from their respective samples (WT 358 ± 105 
pmol/mg; KO 192 ± 65 pmol/mg). Data are mean ± SEM, n = 3–5.
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Adenosine energy transfer molecules differ in KO hippocampus and cortex when compared 
to WT.
(A) The respective ratios of ATP, ADP, AMP, and adenosine relative to the total adenosine 
metabolite concentration in the hippocampi of WT and KO mice (WT: F(3,7)= 85.27; KO: 
F(3, 18) = 6.688, one-way ANOVA with Dunnett’s multiple comparison test). (B) Ratios 
from cortex (WT: F(3, 8) = 75.39; KO: F(3, 18) = 4.514, one-way ANOVA with Dunnett’s 
multiple comparison test). (C-F) Individual coefficient of variation (CV) (as %) in the 
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hippocampus (hip) and cortex (CTX) for (C) ATP, (D) ADP, (E) AMP and (F) adenosine; 
n=3 WT and 6 KO mice. Data analyzed with an unpaired t-test with Welch’s correction.
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Significant variance in the AEC of KO mice.
(A) The adenylate energy charge (AEC) of WT and KO hippocampus (Hip), cortex (CTX) 
and combined (Hip+CTX). (B) The mean coefficient of variation (CV) of AEC is 
comparatively larger in both the hippocampus and cortex of the KO mice, n = 3 WT and 6 
KO mice. Data analyzed using an unpaired t-test with Welch’s correction.
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Synaptic adenosine levels are lower in the CA1sr of the hippocampus in KO mice.
(A) Image of hippocampus from a coronal slice centered over an 8 × 8 multielectrode array. 
MFs were stimulated with an electrode in CA2 (white). Recordings were taken from the sr 
in CA1 (sp indicated by grey line). (B) Example fEPSPs from CA1 pyramidal neurons 
before (a) and after (b) 10 μM XCC. The slope represents the strength of the postsynaptic 
response from stimulation of the MFs (note the increase of negativity of the slope after A1R 
inhibition). (C) Example measurement of the slopes of the fEPSP after stimulation every 
minute before (a) and after (b) 10 μM XCC. (D) Individual fEPSP values before and after 10 
μM XCC in WT and KO mice. (E) Bar chart of adenosine concentrations per mouse (WT: n 
= 7 mice, slices 8, electrodes 45, 304 ± 30 nM; KO: n = 6 mice, 7 slices, electrodes 28, 197 
± 38 nM). CA, cornus ammonis; fEPSP, field excitatory postsynaptic potential; MF, mossy 
fibers; sp., stratum pyrimdale; sr, stratum radiatum.
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Evoked and spontaneous activity of putative orexin neurons is down with increased 
adenosine levels in KO LH.
(A) Example of coronal slice with 8 × 8 MEA placed over the LH. (B) Example trace of 
spontaneous activity in the LH. Top trace is a 300 s recording. Below, examples of 
individual principle cell and interneuron waveforms used to determine principal component 
parameters. (C) Principal component analysis of waveforms distinguish principal cells from 
interneurons based on spike asymmetry (a/b) and spike width (a + b). WT: n = 3 mice, 6 
slices, 200 electrodes; KO n = 4 mice, 9 slices, 197 electrodes. (D) Increases in the slope of 
fEPSPs from stimulated individual principal cells before and after 10 μM XCC (WTcon: 
−493.8 ± 36 μV/ms v. WTXCC: −525 ± 37 μV/ms, n = 49; KOcon: −342.4 ± 53 μV/ms v. 
KOXCC: −396.4 ± 37 μV/ms, n = 22, paired t-test). Note: the statistical increase in baseline 
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fEPSPs of KO compared with WT. (E) Adenosine concentration measurements from evoked 
activity in the LH (WT: 98.09 ± 10.1 nM; KO: 188.7 ± 19.0 nM). (F) Spontaneous activity 
of principal cells before and after A1R antagonist (WTCON: 3.95 ± 1.4 Hz v. WTXCC: 4.94 ± 
1.7 Hz, n = 9 cells; KOCON: 0.80 ± 0.1 Hz v. KOXCC: 1.82 ± 0.6 Hz, n = 10 cells. (G) The 
f.i. was used to calculate the adenosine concentration (WT 243.83 ± 91.3 nM and KO 713.82 
± 177.9 nM). F, fornix; IC, internal capsule; LH, lateral hypothalamus; mt, mamillothalamic 
tract; MEA, multielectrode array; 3 V, third ventricle.
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